The global Biologics Safety Testing Service market size is predicted to grow from US$ 4400 million in 2025 to US$ 8750 million in 2031; it is expected to grow at a CAGR of 12.1% from 2025 to 2031.
Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.
United States market for Biologics Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Biologics Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Biologics Safety Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Biologics Safety Testing Service players cover Merck, Charles River Laboratories, Sartorius, Eurofins Scientific, SGS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淏iologics Safety Testing Service Industry Forecast鈥� looks at past sales and reviews total world Biologics Safety Testing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Biologics Safety Testing Service sales for 2025 through 2031. With Biologics Safety Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Safety Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Biologics Safety Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics Safety Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Biologics Safety Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Safety Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Safety Testing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Safety Testing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Raw Materials
Viral Banks
Cell Banks
Others
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Biologics Safety Testing Service 麻豆原创 Size (2020-2031)
2.1.2 Biologics Safety Testing Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biologics Safety Testing Service by Country/Region (2020, 2024 & 2031)
2.2 Biologics Safety Testing Service Segment by Type
2.2.1 Raw Materials
2.2.2 Viral Banks
2.2.3 Cell Banks
2.2.4 Others
2.3 Biologics Safety Testing Service 麻豆原创 Size by Type
2.3.1 Biologics Safety Testing Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biologics Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Biologics Safety Testing Service Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 CROs and CDMOs
2.4.3 Academic and Research Institutions
2.5 Biologics Safety Testing Service 麻豆原创 Size by Application
2.5.1 Biologics Safety Testing Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biologics Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Biologics Safety Testing Service 麻豆原创 Size by Player
3.1 Biologics Safety Testing Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Biologics Safety Testing Service Revenue by Player (2020-2025)
3.1.2 Global Biologics Safety Testing Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Biologics Safety Testing Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologics Safety Testing Service by Region
4.1 Biologics Safety Testing Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Biologics Safety Testing Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biologics Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Biologics Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Biologics Safety Testing Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Biologics Safety Testing Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Biologics Safety Testing Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Biologics Safety Testing Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Biologics Safety Testing Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Safety Testing Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Biologics Safety Testing Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Biologics Safety Testing Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics Safety Testing Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Biologics Safety Testing Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Biologics Safety Testing Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics Safety Testing Service by Region (2020-2025)
8.2 Middle East & Africa Biologics Safety Testing Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Biologics Safety Testing Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Biologics Safety Testing Service 麻豆原创 Forecast
10.1 Global Biologics Safety Testing Service Forecast by Region (2026-2031)
10.1.1 Global Biologics Safety Testing Service Forecast by Region (2026-2031)
10.1.2 Americas Biologics Safety Testing Service Forecast
10.1.3 APAC Biologics Safety Testing Service Forecast
10.1.4 Europe Biologics Safety Testing Service Forecast
10.1.5 Middle East & Africa Biologics Safety Testing Service Forecast
10.2 Americas Biologics Safety Testing Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Biologics Safety Testing Service Forecast
10.2.2 Canada 麻豆原创 Biologics Safety Testing Service Forecast
10.2.3 Mexico 麻豆原创 Biologics Safety Testing Service Forecast
10.2.4 Brazil 麻豆原创 Biologics Safety Testing Service Forecast
10.3 APAC Biologics Safety Testing Service Forecast by Region (2026-2031)
10.3.1 China Biologics Safety Testing Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Biologics Safety Testing Service Forecast
10.3.3 Korea 麻豆原创 Biologics Safety Testing Service Forecast
10.3.4 Southeast Asia 麻豆原创 Biologics Safety Testing Service Forecast
10.3.5 India 麻豆原创 Biologics Safety Testing Service Forecast
10.3.6 Australia 麻豆原创 Biologics Safety Testing Service Forecast
10.4 Europe Biologics Safety Testing Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Biologics Safety Testing Service Forecast
10.4.2 France 麻豆原创 Biologics Safety Testing Service Forecast
10.4.3 UK 麻豆原创 Biologics Safety Testing Service Forecast
10.4.4 Italy 麻豆原创 Biologics Safety Testing Service Forecast
10.4.5 Russia 麻豆原创 Biologics Safety Testing Service Forecast
10.5 Middle East & Africa Biologics Safety Testing Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Biologics Safety Testing Service Forecast
10.5.2 South Africa 麻豆原创 Biologics Safety Testing Service Forecast
10.5.3 Israel 麻豆原创 Biologics Safety Testing Service Forecast
10.5.4 Turkey 麻豆原创 Biologics Safety Testing Service Forecast
10.6 Global Biologics Safety Testing Service Forecast by Type (2026-2031)
10.7 Global Biologics Safety Testing Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Biologics Safety Testing Service Forecast
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Biologics Safety Testing Service Product Offered
11.1.3 Merck Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Biologics Safety Testing Service Product Offered
11.2.3 Charles River Laboratories Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Sartorius
11.3.1 Sartorius Company Information
11.3.2 Sartorius Biologics Safety Testing Service Product Offered
11.3.3 Sartorius Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Sartorius Main Business Overview
11.3.5 Sartorius Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Biologics Safety Testing Service Product Offered
11.4.3 Eurofins Scientific Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 SGS
11.5.1 SGS Company Information
11.5.2 SGS Biologics Safety Testing Service Product Offered
11.5.3 SGS Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 SGS Main Business Overview
11.5.5 SGS Latest Developments
11.6 Q2 Solutions
11.6.1 Q2 Solutions Company Information
11.6.2 Q2 Solutions Biologics Safety Testing Service Product Offered
11.6.3 Q2 Solutions Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Q2 Solutions Main Business Overview
11.6.5 Q2 Solutions Latest Developments
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Information
11.7.2 Samsung Biologics Biologics Safety Testing Service Product Offered
11.7.3 Samsung Biologics Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Samsung Biologics Main Business Overview
11.7.5 Samsung Biologics Latest Developments
11.8 Texcell
11.8.1 Texcell Company Information
11.8.2 Texcell Biologics Safety Testing Service Product Offered
11.8.3 Texcell Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Texcell Main Business Overview
11.8.5 Texcell Latest Developments
11.9 WuXi Biologics
11.9.1 WuXi Biologics Company Information
11.9.2 WuXi Biologics Biologics Safety Testing Service Product Offered
11.9.3 WuXi Biologics Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 WuXi Biologics Main Business Overview
11.9.5 WuXi Biologics Latest Developments
11.10 Wuhan Canvest Biotechnology
11.10.1 Wuhan Canvest Biotechnology Company Information
11.10.2 Wuhan Canvest Biotechnology Biologics Safety Testing Service Product Offered
11.10.3 Wuhan Canvest Biotechnology Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Wuhan Canvest Biotechnology Main Business Overview
11.10.5 Wuhan Canvest Biotechnology Latest Developments
11.11 Centre Testing International (CTI)
11.11.1 Centre Testing International (CTI) Company Information
11.11.2 Centre Testing International (CTI) Biologics Safety Testing Service Product Offered
11.11.3 Centre Testing International (CTI) Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Centre Testing International (CTI) Main Business Overview
11.11.5 Centre Testing International (CTI) Latest Developments
11.12 Suzhou Liangchen Biotechnology
11.12.1 Suzhou Liangchen Biotechnology Company Information
11.12.2 Suzhou Liangchen Biotechnology Biologics Safety Testing Service Product Offered
11.12.3 Suzhou Liangchen Biotechnology Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Suzhou Liangchen Biotechnology Main Business Overview
11.12.5 Suzhou Liangchen Biotechnology Latest Developments
11.13 JADE Biomedical
11.13.1 JADE Biomedical Company Information
11.13.2 JADE Biomedical Biologics Safety Testing Service Product Offered
11.13.3 JADE Biomedical Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 JADE Biomedical Main Business Overview
11.13.5 JADE Biomedical Latest Developments
11.14 Standard Testing Group
11.14.1 Standard Testing Group Company Information
11.14.2 Standard Testing Group Biologics Safety Testing Service Product Offered
11.14.3 Standard Testing Group Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Standard Testing Group Main Business Overview
11.14.5 Standard Testing Group Latest Developments
11.15 Sino Tech World Biologicals
11.15.1 Sino Tech World Biologicals Company Information
11.15.2 Sino Tech World Biologicals Biologics Safety Testing Service Product Offered
11.15.3 Sino Tech World Biologicals Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Sino Tech World Biologicals Main Business Overview
11.15.5 Sino Tech World Biologicals Latest Developments
11.16 CAS Testing Technical Services
11.16.1 CAS Testing Technical Services Company Information
11.16.2 CAS Testing Technical Services Biologics Safety Testing Service Product Offered
11.16.3 CAS Testing Technical Services Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 CAS Testing Technical Services Main Business Overview
11.16.5 CAS Testing Technical Services Latest Developments
11.17 NTEK
11.17.1 NTEK Company Information
11.17.2 NTEK Biologics Safety Testing Service Product Offered
11.17.3 NTEK Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 NTEK Main Business Overview
11.17.5 NTEK Latest Developments
11.18 Sino Biological
11.18.1 Sino Biological Company Information
11.18.2 Sino Biological Biologics Safety Testing Service Product Offered
11.18.3 Sino Biological Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Sino Biological Main Business Overview
11.18.5 Sino Biological Latest Developments
11.19 Miracle Points
11.19.1 Miracle Points Company Information
11.19.2 Miracle Points Biologics Safety Testing Service Product Offered
11.19.3 Miracle Points Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Miracle Points Main Business Overview
11.19.5 Miracle Points Latest Developments
11.20 Suzhou Cefety Bioscience
11.20.1 Suzhou Cefety Bioscience Company Information
11.20.2 Suzhou Cefety Bioscience Biologics Safety Testing Service Product Offered
11.20.3 Suzhou Cefety Bioscience Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Suzhou Cefety Bioscience Main Business Overview
11.20.5 Suzhou Cefety Bioscience Latest Developments
11.21 Zhejiang Hengyu Biological
11.21.1 Zhejiang Hengyu Biological Company Information
11.21.2 Zhejiang Hengyu Biological Biologics Safety Testing Service Product Offered
11.21.3 Zhejiang Hengyu Biological Biologics Safety Testing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Zhejiang Hengyu Biological Main Business Overview
11.21.5 Zhejiang Hengyu Biological Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.